Necessary, optional, and undesirable drug products

Area of Science:

• Pharmacoeconomics
• Health Policy
• Drug Regulation

Background:

• Drug classification into 'essential' and 'optional' varies by national policies, healthcare economics, and physician/patient choice.
• The World Health Organization (WHO) defines 'Essential Drugs' as fundamental to a nation's health needs.
• Developed nations often include optional drugs, but financial constraints can limit choices.

Purpose of the Study:

• To explore the factors influencing the distinction between necessary and optional drugs.
• To highlight the role of national policies and economic considerations in drug availability.
• To define criteria for identifying and preventing the marketing of undesirable drugs.

Main Methods:

• Analysis of national drug policies and regulatory frameworks.
• Examination of healthcare system economics and reimbursement models.
• Review of criteria for drug safety, efficacy, and quality control.

Main Results:

• Drug selection is influenced by a complex interplay of regulatory, economic, and traditional factors.
• Financial considerations and government payment policies significantly impact the range of available drug choices.
• Generic drug competition can be stimulated in some markets.
• Clear criteria exist for categorizing undesirable drugs based on safety, efficacy, manufacturing, and labeling.

Conclusions:

• National policies and economic factors are pivotal in defining drug necessity and availability.
• Robust criteria are essential to prevent the marketing of unsafe, ineffective, or substandard drugs.
• Balancing therapeutic options with economic realities is a key challenge in drug policy.